THE FDA has approved
carglumic acid tablets, designed for
the treatment of the metabolic
disorder N-acetylglutamate synthase
deficiency, which creates excess
levels of ammonia in the blood.
Trials found that carglumic acid
tablets lowered the amount of
ammonia in the blood within 24 hrs
normalising levels in three days.The above article was sent to subscribers in Pharmacy Daily's issue from 23 Apr 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Apr 10
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.